Fuwei Yang
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Yinan Luo (3 shared papers)Jingwei Zhao (2 shared papers)Pengfei Ge (2 shared papers)Hongwei Zhao (1 shared paper)Boyin Zhang (1 shared paper)Donghui Xu (1 shared paper)Guonan Chi (1 shared paper)Yue Gao (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (3 papers)PLoS ONE (2 papers)Neuroscience (1 paper)Chemico-Biological Interactions (1 paper)Prostate Cancer and Prostatic Diseases (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Fuwei Yang
16 papers receiving 413 citations
Peers
Comparison fields: 5 of 79
- Toxicology 31
- Developmental Neuroscience 17
- Cancer Research 51
- Inorganic Chemistry 44
- Molecular Biology 165
Countries citing papers authored by Fuwei Yang
This map shows the geographic impact of Fuwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuwei Yang more than expected).
Fields of papers citing papers by Fuwei Yang
This network shows the impact of papers produced by Fuwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuwei Yang. The network helps show where Fuwei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fuwei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 124 | |
| 2 | 2020 | 70 | |
| 3 | 2019 | 56 | |
| 4 | 2019 | 45 | |
| 5 | 2012 | 21 | |
| 6 | 2019 | 18 | |
| 7 | 2022 | 17 | |
| 8 | 2013 | 17 | |
| 9 | 2025 | 17 | |
| 10 | 2024 | 11 | |
| 11 | Snail expression contributes to temozolomide resistance in glioblastoma. | 2019 | 11 |
| 12 | 2024 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2006 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Fuwei Yang
Fuwei Yang is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Organic Chemistry, Cellular and Molecular Neuroscience and Neurology, having authored 18 papers that have together received 415 indexed citations. Recurring topics across this work include Neurogenesis and neuroplasticity mechanisms (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Cancer Mechanisms and Therapy (2 papers), Nanoplatforms for cancer theranostics (2 papers), Click Chemistry and Applications (1 paper), Metal-Organic Frameworks: Synthesis and Applications (1 paper), Medical Imaging Techniques and Applications (1 paper) and Axon Guidance and Neuronal Signaling (1 paper). The work is most often cited by research in Toxicology (31 citations), Developmental Neuroscience (17 citations), Cancer Research (51 citations), Inorganic Chemistry (44 citations) and Molecular Biology (165 citations). Fuwei Yang has collaborated with scholars based in China and United States. Frequent co-authors include Yinan Luo, Jingwei Zhao, Pengfei Ge, Hongwei Zhao, Boyin Zhang, Donghui Xu, Guonan Chi, Yue Gao, Wenxiang Huang and Junna Wang. Their work appears in journals such as European Journal of Medicinal Chemistry, PLoS ONE, Neuroscience, Chemico-Biological Interactions and Prostate Cancer and Prostatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.